2010
DOI: 10.1016/j.transproceed.2010.08.027
|View full text |Cite
|
Sign up to set email alerts
|

Preferential Adherence to Immunosuppressive Over Nonimmunosuppressive Medications in Kidney Transplant Recipients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
15
0
2

Year Published

2013
2013
2019
2019

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 22 publications
(19 citation statements)
references
References 27 publications
2
15
0
2
Order By: Relevance
“…This effect may be due in part to the perceived importance of medications with progressive comorbidity. This has been reported in transplant recipients, in which preferential adherence is associated with immunosuppressant treatment (20). Chiu et al (21) reported a positive association of phosphate binder pill burden and nonadherence in a chronic dialysis population.…”
Section: Discussionmentioning
confidence: 73%
“…This effect may be due in part to the perceived importance of medications with progressive comorbidity. This has been reported in transplant recipients, in which preferential adherence is associated with immunosuppressant treatment (20). Chiu et al (21) reported a positive association of phosphate binder pill burden and nonadherence in a chronic dialysis population.…”
Section: Discussionmentioning
confidence: 73%
“…Renal transplant recipients may also have preferential adherence to their immunosuppressant therapy over nonimmunosuppressant therapy including antihypertensive medications. This was shown by Terebelo et al, who demonstrated adherence rates of 81.6% to immunosuppressant therapy versus 55.1% to nonimmunosuppressant therapy among renal transplant recipients in New York, USA ( p = 0.028) [9]. Other predictors of uncontrolled hypertension among renal transplant recipients include older recipient and donor age, male sex, higher levels of proteinuria, and low GFR, as well as cyclosporine and steroid use [1013].…”
Section: Introductionmentioning
confidence: 98%
“…Malnutrition is prevalent in the dialysis population, and the lack of reimbursement for nutritional support can be a barrier to patients as the criteria for qualification can be strict [22]. Optimizing patient education may also be the key to improving outcomes, given the occurrence of non-adherence to treatment plans and the burden of polypharmacy [23,24]. Continuous patient-specific education on the benefits of treatment and the consequences of non-adherence, communicated in understandable and culturally sensitive terms may help to motivate patients and ensure their active and effective participation.…”
Section: Discussionmentioning
confidence: 99%